C.M. Bidwell & Associates’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-130
| Closed | -$2.64K | – | 582 |
|
2023
Q2 | $2.64K | Hold |
130
| – | – | ﹤0.01% | 441 |
|
2023
Q1 | $2.37K | Buy |
+130
| New | +$2.37K | ﹤0.01% | 444 |
|
2022
Q2 | – | Sell |
-3,015
| Closed | -$95K | – | 540 |
|
2022
Q1 | $95K | Hold |
3,015
| – | – | 0.06% | 243 |
|
2021
Q4 | $122K | Buy |
+3,015
| New | +$122K | 0.08% | 224 |
|
2021
Q2 | – | Sell |
-2,520
| Closed | -$71K | – | 612 |
|
2021
Q1 | $71K | Buy |
+2,520
| New | +$71K | 0.05% | 269 |
|